Suppr超能文献

休克、弥散性血管内凝血和中风中的器官损伤。

Organ damage in shock, disseminated intravascular coagulation, and stroke.

作者信息

Hardaway R M

机构信息

Dept. of Surgery, Texas Tech University, School of Medicine, El Paso 79906.

出版信息

Compr Ther. 1992 Nov;18(11):17-21.

PMID:1478053
Abstract

Disseminated intravascular coagulation (DIC) may cause multiple organ failure. Although DIC may cause capillary occlusion in any and all organs, the lungs, liver, kidneys, gut, heart and brain are particularly affected. Focal brain necrosis can also be caused by DIC. Fibrinolytic therapy will often restore significant blood flow to the capillaries of the lungs. This results in significant increase in lung function because the lung is more resistant to actual necrosis and will resume function once circulation is restored. Administration of fibrinolytic therapy will also prevent liver and kidney failure if started within four hours after trauma. This therapy, when given in low doses intravenously over a twenty-four hour period, has little effect on the coagulation mechanism, and abnormal bleeding, therefore, has not been a concern. It is speculated that if plasminogen activators are effective and safe for treating the intravascular clots of DIC, then perhaps they would be effective in treating other types of intravascular coagulation in the brain, such as various types and degrees of stroke.

摘要

弥散性血管内凝血(DIC)可能导致多器官功能衰竭。尽管DIC可导致任何及所有器官的毛细血管阻塞,但肺、肝、肾、肠道、心脏和大脑尤其易受影响。DIC还可引起局灶性脑坏死。纤维蛋白溶解疗法通常可使肺部毛细血管恢复显著的血流。这会使肺功能显著增强,因为肺对实际坏死的耐受性更强,一旦循环恢复就能恢复功能。如果在创伤后四小时内开始使用纤维蛋白溶解疗法,还可预防肝肾功能衰竭。这种疗法在24小时内静脉低剂量给药时,对凝血机制影响很小,因此,异常出血并非问题。据推测,如果纤溶酶原激活剂对治疗DIC的血管内血栓有效且安全,那么它们或许也能有效治疗大脑中其他类型的血管内凝血,比如各种类型和程度的中风。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验